HEADER HYDROLASE INHIBITOR 13-NOV-00 1HD9 TITLE THE BOWMAN-BIRK INHIBITOR REACTIVE SITE LOOP SEQUENCE REPRESENTS AN TITLE 2 INDEPENDENT STRUCTURAL BETA-HAIRPIN MOTIF COMPND MOL_ID: 1; COMPND 2 MOLECULE: BOWMAN-BIRK INHIBITOR DERIVED PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: REACTIVE SITE LOOP I; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630 KEYWDS PEPTIDE INHIBITOR, BOWMAN-BIRK INHIBITOR PROTEIN MIMETIC, HUMAN KEYWDS 2 ELASTASE INHIBITOR, TYPE VIB BETA-TURN PEPTIDE, HYDROLASE INHIBITOR EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR A.B.E.BRAUER,G.KELLY,J.D.MCBRIDE,R.M.COOKE,S.J.MATTHEWS, AUTHOR 2 R.J.LEATHERBARROW REVDAT 5 15-NOV-23 1HD9 1 ATOM REVDAT 4 24-JUL-19 1HD9 1 SOURCE LINK REVDAT 3 13-JUL-11 1HD9 1 VERSN REVDAT 2 24-FEB-09 1HD9 1 VERSN REVDAT 1 29-MAR-01 1HD9 0 JRNL AUTH A.B.E.BRAUER,G.KELLY,J.D.MCBRIDE,R.M.COOKE,S.J.MATTHEWS, JRNL AUTH 2 R.J.LEATHERBARROW JRNL TITL THE BOWMAN-BIRK INHIBITOR REACTIVE SITE LOOP SEQUENCE JRNL TITL 2 REPRESENTS AN INDEPENDENT STRUCTURAL BETA-HAIRPIN MOTIF JRNL REF J.MOL.BIOL. V. 306 799 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11243789 JRNL DOI 10.1006/JMBI.2000.4410 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.D.MCBRIDE,H.N.M.FREEMAN,R.J.LEATHERBARROW REMARK 1 TITL SELECTION OF HUMAN ELASTASE INHIBITORS FROM A REMARK 1 TITL 2 CONFORMATIONALLY-CONSTRAINED COMBINATORIAL PEPTIDE LIBRARY REMARK 1 REF EUR.J.BIOCHEM. V. 266 403 1999 REMARK 1 REFN ISSN 0014-2956 REMARK 1 PMID 10561580 REMARK 1 DOI 10.1046/J.1432-1327.1999.00867.X REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE REMARK 4 REMARK 4 1HD9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-NOV-00. REMARK 100 THE DEPOSITION ID IS D_1290004390. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.8 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : TOCSY; COSY; NOESY; ROESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 22 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING 1H-NMR. THE PAIRWISE REMARK 210 RMSD FOR FAMILY OF 30 STRUCTURES IS 0.61+/ -0.19A FOR THE REMARK 210 BACKBONE ATOMS AND 1.94+/-0.51A FOR ALL HEAVY ATOMS. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 DETAILS ABOUT PEPTIDE DESIGN ARE DESCRIBED IN REFERENCE 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 4 ALA A 4 60.15 -65.27 REMARK 500 5 CYS A 10 66.02 -113.64 REMARK 500 6 ALA A 4 60.83 -65.03 REMARK 500 8 ALA A 4 59.12 -68.30 REMARK 500 10 ALA A 4 64.28 -64.06 REMARK 500 11 ALA A 4 60.32 -65.41 REMARK 500 13 ALA A 4 59.45 -67.58 REMARK 500 13 CYS A 10 68.51 -116.58 REMARK 500 17 ALA A 4 60.86 -65.23 REMARK 500 18 ALA A 4 63.39 -68.32 REMARK 500 19 ALA A 4 61.87 -64.85 REMARK 500 20 ALA A 4 65.41 -65.51 REMARK 500 23 ALA A 4 59.93 -66.44 REMARK 500 25 ALA A 4 63.07 -65.41 REMARK 500 27 ALA A 4 60.46 -65.30 REMARK 500 27 CYS A 10 76.37 -117.57 REMARK 500 28 ALA A 4 61.94 -64.82 REMARK 500 29 ALA A 4 58.86 -68.83 REMARK 500 30 ALA A 4 60.10 -66.41 REMARK 500 REMARK 500 REMARK: NULL DBREF 1HD9 A 1 11 PDB 1HD9 1HD9 1 11 SEQRES 1 A 11 NLE CYS THR ALA SER ILE PRO PRO GLN CYS TYR MODRES 1HD9 NLE A 1 LEU NORLEUCINE HET NLE A 1 21 HETNAM NLE NORLEUCINE FORMUL 1 NLE C6 H13 N O2 SSBOND 1 CYS A 2 CYS A 10 1555 1555 2.03 LINK C NLE A 1 N CYS A 2 1555 1555 1.33 CISPEP 1 ILE A 6 PRO A 7 1 0.01 CISPEP 2 ILE A 6 PRO A 7 2 0.12 CISPEP 3 ILE A 6 PRO A 7 3 0.06 CISPEP 4 ILE A 6 PRO A 7 4 -0.03 CISPEP 5 ILE A 6 PRO A 7 5 0.03 CISPEP 6 ILE A 6 PRO A 7 6 0.07 CISPEP 7 ILE A 6 PRO A 7 7 0.10 CISPEP 8 ILE A 6 PRO A 7 8 0.10 CISPEP 9 ILE A 6 PRO A 7 9 0.05 CISPEP 10 ILE A 6 PRO A 7 10 0.08 CISPEP 11 ILE A 6 PRO A 7 11 -0.03 CISPEP 12 ILE A 6 PRO A 7 12 0.00 CISPEP 13 ILE A 6 PRO A 7 13 0.12 CISPEP 14 ILE A 6 PRO A 7 14 0.05 CISPEP 15 ILE A 6 PRO A 7 15 -0.05 CISPEP 16 ILE A 6 PRO A 7 16 0.04 CISPEP 17 ILE A 6 PRO A 7 17 0.05 CISPEP 18 ILE A 6 PRO A 7 18 0.06 CISPEP 19 ILE A 6 PRO A 7 19 0.05 CISPEP 20 ILE A 6 PRO A 7 20 0.03 CISPEP 21 ILE A 6 PRO A 7 21 0.03 CISPEP 22 ILE A 6 PRO A 7 22 -0.02 CISPEP 23 ILE A 6 PRO A 7 23 -0.02 CISPEP 24 ILE A 6 PRO A 7 24 -0.01 CISPEP 25 ILE A 6 PRO A 7 25 0.03 CISPEP 26 ILE A 6 PRO A 7 26 0.13 CISPEP 27 ILE A 6 PRO A 7 27 -0.02 CISPEP 28 ILE A 6 PRO A 7 28 0.10 CISPEP 29 ILE A 6 PRO A 7 29 0.01 CISPEP 30 ILE A 6 PRO A 7 30 0.12 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 N NLE A 1 -0.844 -7.481 3.049 1.00 0.00 N HETATM 2 CA NLE A 1 -1.629 -6.587 2.158 1.00 0.00 C HETATM 3 C NLE A 1 -1.145 -5.144 2.259 1.00 0.00 C HETATM 4 O NLE A 1 -0.537 -4.751 3.254 1.00 0.00 O HETATM 5 CB NLE A 1 -3.103 -6.680 2.553 1.00 0.00 C HETATM 6 CG NLE A 1 -3.757 -7.995 2.160 1.00 0.00 C HETATM 7 CD NLE A 1 -3.798 -8.167 0.650 1.00 0.00 C HETATM 8 CE NLE A 1 -5.175 -8.574 0.170 1.00 0.00 C HETATM 9 H2 NLE A 1 -1.481 -8.230 3.387 1.00 0.00 H HETATM 10 H NLE A 1 -0.061 -7.876 2.490 1.00 0.00 H HETATM 11 H3 NLE A 1 -0.487 -6.907 3.839 1.00 0.00 H HETATM 12 HA NLE A 1 -1.511 -6.927 1.139 1.00 0.00 H HETATM 13 HB2 NLE A 1 -3.644 -5.877 2.074 1.00 0.00 H HETATM 14 HB3 NLE A 1 -3.185 -6.568 3.624 1.00 0.00 H HETATM 15 HG2 NLE A 1 -4.766 -8.013 2.544 1.00 0.00 H HETATM 16 HG3 NLE A 1 -3.193 -8.808 2.590 1.00 0.00 H HETATM 17 HD2 NLE A 1 -3.095 -8.934 0.362 1.00 0.00 H HETATM 18 HD3 NLE A 1 -3.535 -7.231 0.180 1.00 0.00 H HETATM 19 HE1 NLE A 1 -5.342 -9.616 0.397 1.00 0.00 H HETATM 20 HE2 NLE A 1 -5.242 -8.422 -0.897 1.00 0.00 H HETATM 21 HE3 NLE A 1 -5.922 -7.972 0.667 1.00 0.00 H